T1	Participants 111 162	hyperphosphatemia in hemodialysis patients in Japan
T2	Participants 283 316	86 hemodialysis patients in Japan
T3	Participants 768 911	Of the 86 patients, 62 finished the study without a change of dosage and their data were analyzed (group A, N=16; group B, N=26; group C, N=20)
